National Centre in HIV Social Research, The University of New South Wales, Sydney, Australia.
Drug Alcohol Rev. 2011 Jul;30(4):438-40. doi: 10.1111/j.1465-3362.2011.00288.x. Epub 2011 Mar 31.
Mephedrone (4-methylmethcathinone) is a synthetic stimulant that has recently emerged as a recreational drug. There is currently no Australian data on prevalence and patterns of mephedrone use. This paper aims to explore patterns of mephedrone use among a large sample of same-sex attracted young people in Sydney, Australia.
An online survey was conducted with 572 same-sex attracted men (n= 318) and women (n = 254) aged 18 to 25 years, who lived or regularly spent time in Sydney. Data on mephedrone were collected as part of a larger study exploring sexuality and nightlife.
Mephedrone had been used by 4.0% (n = 23) of respondents, 2.1% (n = 12) in the preceding 6 months, 1.4% (n = 8) in the preceding month. Typical routes of use were intranasal (n = 8) and ingestion (n = 6). No respondent reported ever injecting mephedrone. Three respondents reported polydrug use with mephedrone. The most common contexts of use were respondents' homes or friends' homes (n = 8) and gay bars and clubs (n = 7).
This paper reports low levels of mephedrone use among a large sample of same-sex attracted young people. The proportion of respondents who had used mephedrone was much lower than reported in recent UK research. This may suggest that mephedrone has not infiltrated the Australian market to the same extent as in Europe. However, data from annual surveillance of drug users are required to better determine this.
麦角酸二乙酰胺(4-甲基甲卡西酮)是一种新兴的合成兴奋剂,已成为娱乐性药物。目前,澳大利亚尚无关于麦角酸二乙酰胺使用情况和模式的相关数据。本文旨在探讨澳大利亚悉尼地区大量同性吸引的年轻人使用麦角酸二乙酰胺的情况。
对年龄在 18 至 25 岁之间、居住或经常在悉尼活动的 572 名同性吸引男性(n = 318)和女性(n = 254)进行了在线调查。麦角酸二乙酰胺的数据是作为一项探索性取向和夜生活的更大研究的一部分收集的。
4.0%(n = 23)的受访者曾使用过麦角酸二乙酰胺,其中 2.1%(n = 12)在过去 6 个月内使用过,1.4%(n = 8)在过去一个月内使用过。典型的使用途径为鼻吸(n = 8)和口服(n = 6)。没有受访者报告曾经注射过麦角酸二乙酰胺。有 3 名受访者报告曾与麦角酸二乙酰胺共同使用其他药物。最常见的使用场所是受访者的家和朋友家(n = 8)以及同性恋酒吧和俱乐部(n = 7)。
本文报告了大量同性吸引的年轻人中麦角酸二乙酰胺的低使用水平。使用过麦角酸二乙酰胺的受访者比例远低于最近英国研究报告的比例。这可能表明,与欧洲相比,麦角酸二乙酰胺尚未渗透到澳大利亚市场。然而,需要通过对吸毒者进行年度监测来更好地确定这一点。